Literature DB >> 9922906

Hypogonadotropic hypogonadism.

F J Hayes1, S B Seminara, W F Crowley.   

Abstract

This article outlines the changing pattern of gonadotropin-releasing hormone (GnRH)-induced gonadotropin secretion across sexual development, a knowledge of which is critical to understanding GnRH secretion in pathologic states such as hypogonadotropic hypogonadism. The clinical presentation, differential diagnosis, and treatment of hypogonadotropic hypogonadism in humans are discussed. Particular emphasis is placed on the contribution of frequent sampling studies of gonadotropin secretion and genetic studies to understanding the pathophysiology and clinical heterogeneity of isolated GnRH deficiency in humans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9922906     DOI: 10.1016/s0889-8529(05)70039-6

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  14 in total

Review 1.  Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

Authors:  Claire Bouvattier; Luigi Maione; Jérôme Bouligand; Catherine Dodé; Anne Guiochon-Mantel; Jacques Young
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

2.  Efficacy of recombinant human follicle stimulating hormone at low doses in inducing spermatogenesis and fertility in hypogonadotropic hypogonadism.

Authors:  A A Sinisi; D Esposito; G Bellastella; L Maione; V Palumbo; L Gandini; F Lombardo; A De Bellis; A Lenzi; A Bellastella
Journal:  J Endocrinol Invest       Date:  2010-04-30       Impact factor: 4.256

Review 3.  Stimuli sensitive polymers and self regulated drug delivery systems: a very partial review.

Authors:  Ronald A Siegel
Journal:  J Control Release       Date:  2014-06-28       Impact factor: 9.776

4.  Mechanistic studies of an autonomously pulsing hydrogel/enzyme system for rhythmic hormone delivery.

Authors:  Amardeep S Bhalla; Ronald A Siegel
Journal:  J Control Release       Date:  2014-10-24       Impact factor: 9.776

5.  Clinical, endocrinological, and molecular characterization of Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: a single center experience.

Authors:  Sun-Jeong Shin; Yeonah Sul; Ja Hye Kim; Ja Hyang Cho; Gu-Hwan Kim; Jae Hyun Kim; Jin-Ho Choi; Han-Wook Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2015-03-31

6.  Whole-brain voxel-based morphometry in Kallmann syndrome associated with mirror movements.

Authors:  M Koenigkam-Santos; A C Santos; T Borduqui; B R Versiani; J E C Hallak; J A S Crippa; M Castro
Journal:  AJNR Am J Neuroradiol       Date:  2008-09-03       Impact factor: 3.825

7.  Men with acquired hypogonadotropic hypogonadism treated with testosterone may be fertile.

Authors:  Andjela Drincic; Onur Karamanoglu Arseven; Ernesto Sosa; Moises Mercado; Peter Kopp; Mark E Molitch
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

Review 8.  Male fertility and skin diseases.

Authors:  M Badawy Abdel-Naser; Christos C Zouboulis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 9.306

9.  Pubertal timing predicts adult psychosexuality: Evidence from typically developing adults and adults with isolated GnRH deficiency.

Authors:  Talia N Shirazi; Heather Self; Khytam Dawood; Rodrigo Cárdenas; Lisa L M Welling; Kevin A Rosenfield; Triana L Ortiz; Justin M Carré; Ravikumar Balasubramanian; Angela Delaney; William Crowley; S Marc Breedlove; David A Puts
Journal:  Psychoneuroendocrinology       Date:  2020-06-06       Impact factor: 4.905

Review 10.  Hypogonadotropic hypogonadism revisited.

Authors:  Renato Fraietta; Daniel Suslik Zylberstejn; Sandro C Esteves
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.